US2023295023A1PendingUtilityA1
Decontamination of Environmental Water Sources Using Living Engineered Biofilm Materials
Est. expiryJul 28, 2040(~14 yrs left)· nominal 20-yr term from priority
C12N 1/00C12N 15/10C07K 14/005C02F 3/006C07K 14/472C07K 2319/00C07K 2319/01C07K 7/06C07K 7/08C12N 2760/16031C02F 2101/305C02F 2101/327C02F 2101/36C02F 2101/38C02F 2101/163C02F 2101/105C02F 2101/20C02F 2303/04C02F 3/06C02F 3/101C02F 3/104C02F 3/348C02F 2101/30C02F 1/683C02F 1/50C02F 2101/10
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A living engineered biofilm material comprises microbial cells embedded in a protective extracellular matrix comprising a fusion protein of an amyloid domain and a contaminant binding domain operative to bind a contaminant of a water source, and thereby facilitate decontamination of the water source.
Claims
exact text as granted — not AI-modified1 . A living engineered biofilm material configured for decontamination of an environmental water source, wherein the biofilm material comprises microbial cells embedded in a protective extracellular matrix comprising a fusion protein expressed by the microbial cells, the fusion protein comprising an amyloid domain and a contaminant binding domain operative to bind a contaminant of the water source, and thereby facilitate decontamination of the water source.
2 . The material of claim 1 , wherein the contaminant is selected from a microbial (e.g. viral, bacterial, fungal or protozoan) pathogen, organic dye, antibiotic, artificial sweetener, pharmaceutical, perfluorinated compound, and flame retardant.
3 . The material of claim 1 , wherein the contaminant is a water-transmitted microbial pathogen that is a viral pathogen selected from Adenovirus, Astrovirus, Hepatitis A and E viruses, Rotavirns, Norovirus, Coxsackie viruses, Polioviruses, Polyomaviruses, Cytomegalovirus, Coronaviruses and Influenza viruses, or a bacterial pathogen selected from Aeromonas , Pseudomonas Salmonella , Aeromonas, Shigella , Vibrio spp ., Enterobacter and Klebsiella , or a protozoan pathogen selected from Giardia lamblia and Schistosome .
4 . The material of claim 1 , wherein the contaminant is a harmful chemical in water selected from arsenic, heavy metals, halogenated aromatics, nitrosoamines, nitrates and phosphates.
5 . The material of claim 1 , wherein the contaminant binding domain and contaminant are selected from:
Contaminant binding domain Target contaminant CHKKPSKSC (SEQ ID NO:1) TiO2 binding CHRRPSRSC (SEQ ID NO:2) TiO2 binding AHKKPSKSA (SEQ ID NO:3) TiO2 binding MHGKTQATSGTIQS (SEQ ID NO:4) Gold binding WALRRSIRRQSY (SEQ ID NO:5) Gold binding WAGAKRLVLRRE (SEQ ID NO:6) Gold binding LKAHLPPSRLPS (SEQ ID NO:7) Gold binding VSGSSPDS (SEQ ID NO:8) Gold binding RRTVKHHVN (SEQ ID NO:9) Iron oxide ACTARSPWICG (SEQ ID NO:10) Lanthanide oxide and upconversion nanocrystals MSPHPHPRHHHT (SEQ ID NO:11) silica SSKKSGSYSGSKGSKRRIL (SEQ ID NO:12) silica HPPMNASHPHMH (SEQ ID NO:13) silica RKLPDA (SEQ ID NO:14) silica CTYSRKHKC (SEQ ID NO:15) Cadmium sulphide LRRSSEAHNSIV (SEQ ID NO:16) Zinc sulphide TSNAVHPTLRHL (SEQ ID NO:17) Palladium binding PTSTGQA (SEQ ID NO:18) Platinum binding TLTTLTN (SEQ ID NO:19) Platinum binding SSFPQPN (SEQ ID NO:20) Platinum binding CSQSVTSTKSC (SEQ ID NO:21) Platinum binding AYSSGAPPMPPF (SEQ ID NO:22) silver NPSSLFRYLPSD (SEQ ID NO:23) silver RPRENRGRERGL (SEQ ID NO:24) Titanium RKLPDA (SEQ ID NO:25) Titanium PPPWLPYMPPWS (SEQ ID NO:26) Quartz VKTQATSREEPPRLPSKHRPG (SEQ ID NO:27) Zeolites EAHVMHKVAPRP (SEQ ID NO:28) Zinc oxide EPLQLKM (SEQ ID NO:29) Graphene HSSYWYAFNNKT (SEQ ID NO:30) Single-walled carbon nanotubes DYFSSPYYEQLF (SEQ ID NO:31) Single-walled carbon nanotubes DSPHTELP (SEQ ID NO:32) Single-walled carbon nanotubes.
6 . The material of claim 1 , wherein the contaminant is a viral pathogen and the contaminant binding domain and contaminant are selected from:
Contaminant binding domain peptide Contaminant LRNIRLRNIRLRNIRLRNIR (SEQ ID NO:33) hepatitis B virus IINNPITCMTNGAICWGPCPTAFRQIGNCGHFKVRCCKIR (SEQ ID NO:34) influenza A virus H1N1, IINNPITCMT (SEQ ID NO:35) H3N2, ITCMTNGAIC (SEQ ID NO:36) H5N1, NGAICWGPCP (SEQ ID NO:37) H7N7, WGPCPTAFRQ (SEQ ID NO:38) H7N9, TAFRQIGNCG (SEQ ID NO:39) SARS-CoV and MERS-CoV IGNCGHFKVR (SEQ ID NO:40) HFKVRCCKIR (SEQ ID NO:41) TAFRQIGNCGHFKVRCCKIR (SEQ ID NO:42) NGAICWGPCPTAFRQIGNCGHFKVRCCKIR (SEQ ID NO:43) IINNPITCMTNGAICWGPC (SEQ ID NO:44) IINNPITCMTNGAICWGPCPTAFRQIGNCG (SEQ ID NO:45) NGAICWGPCPTAFRQIGNCGHFKVRCCKIRDED (SEQ ID NO:46) ARLPR (SEQ ID NO:47) (C5) H1N1 CIEQSFTTLFACQTAAEIWRAFGYTVKIMVDNGNCRLHVC (SEQ ID NO:48) (C40) H1N1 IEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNIT (SEQ ID NO:49) Sars-Cov-2 WLVFFVIFYFFR (SEQ ID NO:50) H1N1 WLVFFVIAYFAR (SEQ ID NO:51) WLVFFVIFYFFRRRKK (SEQ ID NO:52) RRKKWLVFFVIFYFFR (SEQ ID NO:53) RRKKIFYFFR (SEQ ID NO:54) WLVFFVRRKK (SEQ ID NO:55) FFVIFYRRKK (SEQ ID NO:56) QMRRKVELFTYMRFD (SEQ ID NO:57) Enterovirus 71 NDFRSKT (SEQ ID NO:58) H9N2 CNDFRSKTC (SEQ ID NO:59) H9N3 GCKKYRRFRWKFKGKFWFWG (SEQ ID NO:60) H7N7 GKKYRRFRWKFKGKWFWFG (SEQ ID NO:61) H3N2 GFWFKGKWRFKKYRGGRYKKFRWKGKFWFG (SEQ ID NO:63) H1N1 SSNKSTTGSGETTTA (SEQ ID NO:63) H1N1.
7 . The material of claim 1 , wherein the contaminant binding domain is an influenza virus hemagglutinin binding peptide selected from: ARLPR (SEQ ID NO:47) (C5) and CIEQSFTTLFACQTAAEIWRAFGYTVKIMVDNGNCRLHVC (SEQ ID NO:48) (C40).
8 . The material of claim 1 , wherein the amyloid domain is of TasA ( B. subtilis ), CsgA ( E. coli ), PSMs ( S. aureus ), RmbC ( V. cholera ), CsgA ( Enterobacter cloacae ), FapC ( Pseudomonas spp .), CsgA ( Salmonella spp .) or PAc ( Streptococcus mutans ).
9 . The material of claim 1 , wherein the amyloid domain is a CsgA monomer.
10 . The material of claim 1 , wherein the microbial cells are Bacillus spp . (e.g. B.subtilis ), Pseudomonas spp. (e.g. P. aeruginosa ), Staphylococcus spp . (e.g. S. aureus ), Salmonella ssp. (e.g. S. enterica ), Vibrio spp. (e.g. V. cholera ), Streptococcus spp . (e.g. Streptococcus mutans ), Enterobacter spp . (e.g. Enterobacter cloacae ), Lactobacillus spp . (e.g. L. plantarum ) or Escherichia spp . (e.g. E. coli ).
11 . The material of claim 8 , wherein the microbial cells are Bacillus spp . (e.g. B.subtilis ), Pseudomonas spp . (e.g. P. aeruginosa ), Staphylococcus spp . (e.g. S. aureus ), Salmonella ssp . (e.g. S. enterica ), Vibrio spp. (e.g. V. cholera ), Streptococcus spp. (e.g. Streptococcus mutans ), Enterobacter spp . (e.g. Enterobacter cloacae ), Lactobacillus spp . (e.g. L. plantarum ) or Escherichia spp . (e.g. E. coli ).
12 . The material of claim 9 , wherein the microbial cells are Bacillus spp. (e.g. B.subtilis ), Pseudomonas spp . (e.g. P. aeruginosa ), Staphylococcus spp . (e.g. S. aureus ), Salmonella ssp. (e.g. S. enterica ), Vibrio spp . (e.g. V. cholera ), Streptococcus spp. (e.g. Streptococcus mutans ), Enterobacter spp. (e.g. Enterobacter cloacae ), Lactobacillus spp . (e.g. L. plantarum ) or Escherichia spp. (e.g. E. coli ).
13 . The material of claim 1 configured in a water decontamination system comprising the living engineered biofilm material, the system further comprising a water source comprising the contaminant.
14 . The material of claim 1 configured in a water decontamination system comprising an industrial filler material colonized by the living engineered biofilm material.
15 . The material of claim 10 configured in a water decontamination system comprising an industrial filler material colonized by the living engineered biofilm material.
16 . The material of claim 11 configured in a water decontamination system comprising an industrial filler material colonized by the living engineered biofilm material.
17 . The material of claim 12 configured in a water decontamination system comprising an industrial filler material colonized by the living engineered biofilm material.
18 . The material of claim 1 configured in a water decontamination system comprising an industrial filler material colonized by the living engineered biofilm material, the system further comprising a water source comprising the contaminant.
19 . A water decontamination system comprising an industrial filler material colonized by the living engineered biofilm material of claim 1 .
20 . A method of using the living engineered biofilm material of claim 1 , comprising the step of contacting a water source comprising the contaminant with the biofilm material under conditions wherein the fusion protein binds the contaminant.Join the waitlist — get patent alerts
Track US2023295023A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.